The RAS family of oncogenes have been shown to contribute to the development and progression of colorectal cancer (CRC),1 with mutations resulting in dysregulated cellular proliferation downstream of epidermal growth factor receptor (EGFR). This evidence concerns the gene EGFR and colorectal cancer.